Sources | Names Used |
---|---|
CTRPv2 | JQ-1:vorinostat (2:1 mol/mol) |
PharmacoGx | JQ-1:vorinostat (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCTD3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | ANKEF1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | ADAMTS6 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | CT55 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | CD59 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | SNX20 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | RELB | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | TNFRSF1B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ST14 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | FASN | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |